Interstitial lung disease-related pneumomediastinum in COVID-19 patients
Open Access
- 1 January 2021
- journal article
- letter
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 7 (1)
Abstract
Pneumomediastinum in severe #COVID19 presentations could be due to a lung parenchymal retractive process generated by intense inflammation as in acute exacerbation of idiopathic pulmonary fibrosis or MDA-5 acute interstitial lung diseasehttps://bit.ly/3qzBYMWKeywords
This publication has 5 references indexed in Scilit:
- Pneumomediastinum and subcutaneous emphysema in COVID-19: barotrauma or lung frailty?ERJ Open Research, 2020
- COVID-19 with spontaneous pneumomediastinumThe Lancet Infectious Diseases, 2020
- Pneumomediastinum in MDA5-associated clinically amyopathic dermatomyositisRheumatology Advances in Practice, 2017
- Spontaneous Pneumomediastinum as a Potential Predictor of Mortality in Patients with Idiopathic Pulmonary FibrosisRespiration, 2016
- Spontaneous pneumomediastinum in patients with severe acute respiratory syndromeEuropean Respiratory Journal, 2004